Omixon Inc
Advertisement
Omixon Inc is a molecular diagnostics company based in Salem, MA that specializes in Next Generation Sequencing (NGS) technologies for histocompatibility labs. Their flagship product, Holotype HLA, is a combination NGS Assay and Software product designed for HLA typing and is used on Illumina sequencers. With a focus on driving innovation and improving transplant outcomes, Omixon has become a global leader in the adoption of NGS in the HLA community.
Omixon's product portfolio also includes NanoTYPE, a nanopore-based long-read sequencing technology that offers a revolutionary change in the clinical routine of HLA genotyping, and NANOTYPE MONO, a single locus testing kit available as a Research Use Only (RUO) product. With a team of key opinion leaders and major collaborators in the HLA community, Omixon has trained HLA labs worldwide and has a strong presence in both Europe and North America. Their dedication to accurate and meaningful data interpretation has made them a trusted partner for laboratories seeking to advance patient care through NGS techniques.
Generated from the website
You might also like
Partial Data by Infogroup (c) 2025. All rights reserved.
Advertisement